Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH.

IF 9.9 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2025-09-26 DOI:10.1002/ajh.70081

Steven Rowe,Mariam Goubran,Mateo Sarmiento Bustamante,Saishravan Shyamsundar,Bridget Austin,Kathleen McNicholas,Marley Blommers,Junyan Shi,Lisa K Peterson,Lusia Sepiashvili,Andre Mattman,Joshua D Brandstadter,David C Fajgenbaum,Luke Y C Chen

引用次数: 0

Abstract

A clinical pathway for differentiating TAFRO from HLH when a cytokine storm is identified, using ferritin, C-reactive protein, and soluble CD25.

查看原文本刊更多论文

铁蛋白、c反应蛋白和可溶性CD25是TAFRO和HLH的区别。

鉴别细胞因子风暴时，使用铁蛋白、c反应蛋白和可溶性CD25鉴别TAFRO和HLH的临床途径

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.